This inventor holds 1 USPTO granted patent. Top assignee: Daewon Pharm., Co., Ltd.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Chankyu Jeoung: Innovator in Pharmaceutical Formulations
Introduction
Chankyu Jeoung is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of oral medications. His innovative work focuses on enhancing the effectiveness and stability of pharmaceutical compounds.
Latest Patents
Chankyu Jeoung holds a patent for an oral pharmaceutical formulation of pelubiprofen with improved dissolution rate and stability. This formulation is designed to enhance the dissolution rate of pelubiprofen, leading to high bioavailability and rapid pharmacological effects. Additionally, the formulation exhibits high stability, minimizing the generation of related compounds during storage. He has 1 patent to his name.
Career Highlights
Chankyu Jeoung is currently employed at Daewon Pharm., Co., Ltd., where he continues to develop innovative pharmaceutical solutions. His work is characterized by a commitment to improving drug formulations for better patient outcomes.
Collaborations
Chankyu has collaborated with talented coworkers, including Joungmin Han and Sehhyon Song, to advance their research and development efforts in the pharmaceutical industry.
Conclusion
Chankyu Jeoung's contributions to pharmaceutical formulations demonstrate his dedication to innovation and improving drug efficacy. His work not only enhances the stability and bioavailability of medications but also reflects the importance of collaboration in scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile